Cannabis Stocks Rally After Rescheduling News: Investment Management Firm Co-Founder Discusses Impact and Next Steps

T he recent announcement from the U.S. Department of Justice proposing the reclassification of cannabis from a Schedule I to a Schedule III drug has ignited a profound surge in the cannabis industry.